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REFLECTIONS OF THE PIONEERSThe origins of open heart surgery at the University of Minnesota 1951
to 1956Richard A. DeWall, MDAs a senior medical student in May 1951, I recall the excite-
ment in the surgery department when Dr Clarence Dennis,
who later became Chairman at Downstate University in
New York, and his staff were in an operating suite to repair
an atrial septal defect in a child by using open heart surgical
techniques. They were using a heart–lung machine of the
team’s design; later, a second procedure was performed,
but neither effort was successful.
In September 1952, approximately 1 year before the
Minnesota cross-circulation experiments were initiated,
Dr F. John Lewis made his mark in the surgical world
with the first successful open heart procedure for the direct
closure of an atrial septal defect. This was accomplished by
reducing a patient’s body temperature 10 degrees below
normal. At this temperature, the patient’s circulation could
be stopped for up to 15 minutes, which fully protected the
brain and was enough time for the direct repair of an atrial
septal defect.
The patient’s body temperature was reduced by immer-
sion into a tub of ice water contained in a watering tank
as used on a horse farm. A horse watering tank seemed an
unlikely addition to a modern operating room. Dr C.Walton
Lillehei assisted Dr Lewis with his hypothermia operations.
The closure of an atrial septal defect was made through the
atrial wall. Intraventricular defects required a ventriculot-
omy. A cold ventricle will fibrillate when incised. Convert-
ing the heart back to a normal sinus rhythm after closure of
the ventricular incision while cold was difficult, leading
Dr Lillehei to seek amethod that would allow a transventric-
ular approach in a warm heart.
Dr Norman Shumway, who later became director of the
cardiothoracic program at Stanford University, served as
the director of Dr Lewis’s laboratory, which was adjacent
to that of Dr Lillehei. Dr Lewis later joined the staff at
Northwestern University.
Camaraderie prevailed throughout the department.
Dr Shumway frequently visited Dr Lillehei’s laboratory to
keep up to date with our experiments, and we would check
into Dr Lewis’s laboratory to follow Dr Shumway’s work
with cardiac hypothermia.
After completing a military internship in New York,
I returned to Minnesota in 1953. My interest was to workFrom the Wright State University, Dayton, Ohio.
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The Journal of Thoracic and Cain laboratory medicine. I returned to my medical school
to seek the advice of Dr Richard Varco, one of my surgery
professors when I was a student. Dr Varco’s secretary told
me Dr Varco was in the operating room, and he would see
me when he finished. As was customary at that time, I
walked into the operating suite in street clothes to wait until
Dr Varco finished his case. Scrub clothes, cap, and mask
were required only within the actual operating room.
Dr Varco met me outside the operating suite. I mentioned
to him my interest in laboratory medicine, similar to that of
Dr Dennis. I showed him a plaster of Paris mock-up of a bi-
leaflet valve that I made and envisioned could be developed
into a prosthetic mitral valve. Dr Varco was receptive to my
ideas, and he arranged for me to meet Dr C.Walton Lillehei.
Dr Lillehei, whose interest was in the development of open
heart surgery, introduced me to the director of his labora-
tory, Dr Herbert Warden, who later became chief of cardio-
thoracic surgery at the University of West Virginia.
Dr Morley Cohen, who later became chief of cardiotho-
racic surgery at the University of Manitoba in Winnipeg,
preceded Dr Warden as director of Dr Lillehei’s animal
laboratory. During this transition in Dr Lillehei’s laboratory,
the two discussed the possibilities of open heart surgery. Dr
Cohen’s wife was pregnant at the time, and the thought of
the fetus being supported by blood from the womb of
a mother prompted discussion of using a donor dog as an
oxygenator to support a recipient dog.
I began work with Dr Warden in March 1954. To test the
concept of a donor being the oxygenator in a cardiac bypass
system to permit open heart surgery, Dr Warden and I
placed the patient dog and the donor dog on respective
tables. We performed the proper arterial and venous cannu-
lations and then opened the patient dog’s chest for a sham
open heart operation. The dog’s arterial and venous cannu-
las were connected by plastic tubes running through a stan-
dard laboratory pump that controlled a balanced arterial and
venous flow of blood between the donor and the recipient
animals. Because I had no surgical experience, Dr Warden
performed the surgery while I operated the pump. The
procedure was called ‘‘controlled cross-circulation.’’
After many dozens of these sham procedures in dogs,
Drs Warden, Cohen, and Lillehei were confident in taking
the procedure into clinical application. Because I had the
experience in managing the pump during the laboratory
experiments, I was designated as the clinical perfusionist.
The clinical application of controlled cross-circulation
was controversial because of an ethical conflict involving
a surgical procedure on a normal donor. Permission tordiovascular Surgery c Volume 142, Number 2 267
FIGURE 1. Helical reservoir pump oxygenator, 1955.
Reflections of the Pioneers DeWallproceedwith the surgery had to be reviewed and approved by
the surgical department chairman, Dr Owen Wagensteen.
After a proper review, Dr Wagensteen wrote a note to
Dr Lillehei, ‘‘by all means go ahead, OHW.’’ DrWagensteen
was revered and respected by all for the educational pro-
grams he developed and the opportunities he provided for
this entire staff.
The first clinical operation using cross-circulation was in
March 1954. While walking back to the recovery room after
a cross-circulation procedure, Dr Lillehei and I discussed
the desirability of replacing the donor of the controlled
cross-circulation with an artificial oxygenator. I became di-
rector of Dr Lillehei’s laboratory while Dr Warden returned
to his clinical activities. Attempts to build an oxygenator
had been tried before by Drs John Gibbons, Clarence
Dennis, and others. No pump-oxygenator system at that
time proved to be generally acceptable.
Dr Lillehei mentioned that work on a mechanical blood
oxygenator would be a good research project if I would
be interested. I agreed that I would like to take on the pro-
ject. He gave me 2 admonitions: (1) Avoid bubble systems,
because they had such a bad record for perfusion support,
and (2) do not do a literature search so as to avoid a prejudice
toward one system or another. I worked with this objective
in mind and began my research on the oxygenator project in
the afternoons and evenings after manning the pump for the
cross-circulation surgery in the mornings.
Dr Lillehei suggested that for the oxygenator design I
might find use for a polyvinyl hose similar to that used in
the food industry. The company of a friend of Dr Lillehei’s
produced such a hose. The suggested use of polyvinyl was
fortuitous because glass as used in other oxygenator systems
and known to activate thromboplastin, destroying the clot-
ting mechanism of blood. Polyvinyl is blood compatible.
After 6 months of research, including several unsuccess-
ful failed attempts at differing oxygenator systems, the
helical reservoir bubble oxygenator proved successful.
The same laboratory pump as used with cross-circulation
procedures served with the helical bubble oxygenator to
complete a successful heart–lung machine (Figure 1). The
helical reservoir bubble oxygenator soon achieved wide ap-
plication because it cost less than $20 to construct, could be
autoclaved, was used once, and discarded. The Gibbon ver-
tical screen pump oxygenator designed by Dr Gibbon in
Philadelphia was a large unit ( 30340340) made of stain-
less steel, cost many thousands of dollars, and was difficult
to clean and sterilize for reuse.
In May 1955, after many sham animal operations and 6
months of work with my research on the helical reservoir
oxygenator, I was confident that the system would work.
Dr Lillehei then proceeded with a successful open heart
surgery operation in an infant using the helical reservoir
oxygenator system (DeWall oxygenator). Hundreds of
cases were to follow.268 The Journal of Thoracic and Cardiovascular SurgIn 1954, Dr John Kirklin’s team at the Mayo Clinic devel-
oped their own open heart surgical program. Their first open
heart surgical procedure in March 1955 used their version of
the Gibbon’s pump-oxygenator (the Mayo-Gibbon oxygena-
tor). A free exchange developed between the teams of
Dr Kirklin and Dr Lillehei about their increasing experience
in open heart surgery. Members from the Minneapolis team
visited the Mayo Clinic, as did Mayo Clinic personnel visit
the University of Minnesota’s open heart surgery program.
World-renownedcardiac surgeonsvisitedDrLillehei’s service
and made the trip 90 miles south to the Mayo Clinic. It was
a great thrill for me to meet these famous surgeons to show
them all we had developed for perfusion and open heart sur-
gery. In 1955, the openheart surgical programs atMinneapolis
and Rochester Minnesota were the only places in the world
where open heart surgery was performed on a regular basis.
Other interesting cardiac surgical problems were investi-
gated at Minnesota simultaneously with the oxygenator.
Dr Wangensteen’s general surgical laboratory was adjacent
to that of Drs Lewis and Lillehei. His laboratory director
was Dr Earl Yonehiro. Earl, a Japanese American, served
as a sniper sharpshooter in Italy during World War II.
Dr Yonehiro’s interest included cardiovascular subjects.ery c August 2011
DeWall Reflections of the PioneersIn 1955, he initiated surgical experiments on the anastomo-
sis of the left internal mammary artery to the left anterior
descending coronary artery in dogs. He was ahead of the
time in coronary artery surgery.
Surgically induced heart block presented a problem with
some of the earlier ventricular septal defect repairs because
intracardiac conduction anatomy was not well understood
at that time. Dr Wagensteen conducted a surgical morbidity
and mortality seminar every Saturday. All residents and sur-
gical staff were expected to attend. Surgically induced com-
plete heart block was discussed at several successive
meetings. Dr Jack Johnson, a member of the physiology de-
partment, regularly attended the seminar. After a discussion
during one session on heart block, Dr Johnson mentioned
the application of a Grass Simulator, as used in physiology
classes, to stimulate and study contraction of a frog’s leg
muscles. The Grass Stimulator produced a small voltage
electrical charge. Dr Johnson suggested that such a charge
would be an effective way to stimulate a patient’s heart in
complete heart block.
A couple of days later, Drs Vincent Gott and William
Weirich went to the animal laboratory and set up an experi-
mental heart block preparation. By using the Grass Stimula-
tor, as suggested byDr Johnson, they implanted an electrical
wire into the dog’s heart muscle and applied the stimulator.
They were able to control the heart block as predicted.
In January 1957, a complete heart block developed in
a child with a ventricular septal defect after a repair by
Dr Lillehei. Dr Lillehei sent for Drs Gott and Weirich and
the Grass Stimulator. Dr Lillehei inserted an insulated
wire into the heart muscle of the patient and connected it
to the stimulator. The procedure worked and controlled
the total heart block.
The Grass Stimulator was about the size of a portable
typewriter and required an AC outlet. A 100-foot extension
cord was necessary to move the patient from the operating
room to the recovery room. Dr Lillehei asked Earl Bakken,
an electrical engineer who assisted the surgical department
as an electronics consultant, to miniaturize the Grass
Stimulator system. In April 1958, after approximatelyThe Journal of Thoracic and Ca2 weeks, Earl Bakken returned with a stimulator 2 times
the size of a pack of playing cards. It served the pacemaker
purpose well and was the start of the Medtronic Company
(Minneapolis, Minn).
I never applied for a surgical residency in Dr Wagens-
teen’s department of surgery, but after 2.5 years in research
I was assigned to the clinical services. Dr Vincent Gott was
my replacement in Dr Lillehei’s laboratory to continue the
work on oxygenator systems. He worked with prosthetic
heart valves and later became chief of cardiothoracic sur-
gery at Johns Hopkins University.
In the mid-1950s, Dr Christian Barnard joined
Dr Wagensteen’s group of residents. Early on, he showed
interest in the open heart surgery program. Dr Barnard later
served on Dr Lillehei’s heart surgery service. Dr Barnard
was offered an opportunity to stay on at the University of
Minnesota, but he elected to return to his academic home,
the University of Cape Town in South Africa, where he
directed their heart surgery program. The first clinical heart
transplant was performed there.
Dr Aldo Castenada became attached to Dr Lillehei’s
surgical program shortly after my time in the laboratory.
Sometime later, Dr Castenada became the chief of cardio-
vascular surgery at Boston Children’s Hospital.
In 1962, I was offered the opportunity to become Chair-
man of Surgery at the Chicago Medical School and moved
to Chicago. Subsequently, I moved to Kettering Hospital in
Dayton Ohio and Wright State Medical School.
There were many talented heart surgeons who graduated
from Dr Lillehei’s residency program and developed repu-
table heart surgery programs around the world.1-3I extend my appreciation to Dr Sylvan Weinberg for the gener-
ous help in editing this article.
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